Association of chronic subclinical inflammation with severity and progression of rheumatic valve disease

International Journal of Cardiology

Volumn 124, Issue 2, 2008, Pages 263-

  Sari, Ibrahim ^a   Davutoglu, Vedat ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Inflammation; Rheumatic valve disease

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SYMPTOM;

CYTOKINES; DISEASE PROGRESSION; FEMALE; HEART VALVE DISEASES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHEUMATIC HEART DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 38749104246     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.12.038     Document Type: Article

References (3)

1. Turhan H., and Yetkin E. What are the impacts of chronic subclinic inflammation in patients with rheumatic mitral stenosis?. Int J Cardiol 117 1 (Apr 12 2007) 140
2. Harikrishnan S., Rajeev E., Tharakan J.A., et al. Acute phase reactants predict mitral regurgitation following mitral valvuloplasty. Int J Cardiol 112 1 (Sep 10 2006) 127-129
3. Davutoglu V., Celik A., and Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 14 2 (Mar 2005) 251-256